Concepedia
Statistics
Publications
5
Citations
145
H-Index
Active since
2023
Affiliations
Harvard University(Current)
Harvard Stem Cell Institute
Brigham and Women's Hospital
Massachusetts General Hospital
Thijs van Schaik is an author at Harvard University specializing in immunotherapy, oncology, and cancer immunotherapy.
Publications per year
2023–2024
Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity
Kok‐Siong Chen, Clemens Reinshagen, Thijs van Schaik et al. · Science Translational Medicine · 2023 · 74 citations · Full text
Life Sciences, Immunology, Oncology +17
Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas
Nobuhiko Kanaya, Yohei Kitamura, María López Vázquez et al. · Science Translational Medicine · 2023 · 26 citations · Full text
Medicine, Immunology, Oncology +17
Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors
Thijs van Schaik, Lucia Moreno-Lama, Touraj Aligholipour Farzani et al. · Biomedicine & Pharmacotherapy · 2023 · 16 citations · Full text
Pharmacy, Bioengineering, Oncology +17
Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138
Jort J. van der Schans, Ziyu Wang, Jennemiek van Arkel et al. · Clinical Cancer Research · 2023 · 16 citations
Life Sciences, Hematology, Immunology +17
Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice
Longsha Liu, Thijs van Schaik, Kok‐Siong Chen et al. · Frontiers in Immunology · 2024 · 13 citations · Full text
1–5 of 5